Safety of ginger use in pregnancy: results from a large population-based cohort study
European Journal of Clinical Pharmacology, 07/10/2012
Heitmann K et al. – Use of ginger during pregnancy does not seem to increase the risk of congenital malformations, stillbirth/perinatal death, preterm birth, low birth weight, or low Apgar score. This finding is clinically important for health care professionals giving advice to pregnant women with NPV.
Methods- The Norwegian Mother and Child Cohort study, a large population–based cohort, provided the data used in this study.
- This study population consisted of 68,522 women.
- Data on ginger use and socio–demographic factors were retrieved from three self–administered questionnaires completed by the women during weeks 17 and 30 of the pregnancy and when their child was 6 months old.
- Data on pregnancy outcomes were provided by the Medical Birth Registry of Norway.
- Among the 68,522 women in the study, 1,020 (1.5 %) women reported using ginger during pregnancy.
- The use of ginger during pregnancy was not associated with any increased risk of congenital malformations.
- No increased risk for stillbirth/perinatal death, preterm birth, low birth weight, or low Apgar score was detected for the women exposed to ginger during pregnancy compared to women who had not been exposed.



